Home › NCT06274385

The Effects of an Acute Dose of a Betalain-rich Concentrate on Repeated-sprint Cycling Performance and Recovery.

The Effects of an Acute Dose of a Betalain-rich Concentrate on Repeated-sprint Cycling Performance and Recovery: A Randomized, Double-blind, Crossover, Placebo-control Study.

Who can join

Ages 18 to 40 · All sexes · Healthy volunteers welcome

Inclusion Criteria:

* Healthy, recreationally active males and females
* Aged 18-40
* Free of disease or injury

Exclusion Criteria:

* Have any musculoskeletal injuries that could be made worse by participating in this study (e.g., sprain or strain of lower limb)
* Have documented medical conditions (i.e., hypertension, asthma, heart disease, diabetes) or exhibit signs and symptoms of medical conditions
* Taking any medication that would interfere with the interpretation of our results. These include, but are not limited to, anti-inflammatory drugs, antibiotics, anti-hypertensives, and any medicine controlling the digestive system.

About the study

Betalains have well-known antioxidant and anti-inflammatory properties. Recent investigations examining the effects of a betalain-rich concentrate (BRC) on exercise and recovery performance show promise of BRC as an ergogenic aid. To date, no study has examined the effects of a single dose of a BRC on supramaximal performance and recovery. Therefore, the purpose of this study is to examine the effects of an acute dose of BRC on repeated-sprint cycling performance and recovery.

What is being tested

• Betalain-rich concentrate (AltRed) (dietary supplement)
• Placebo (other)

Sponsor: Drexel University · Participants: 10 · Started: Mar 6, 2024

Contact the study team

Official record on ClinicalTrials.gov — NCT06274385

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.